$65.03
-0.41-0.63%
Last update: Nov 9, 4:04 PM
PTC Therapeutics Inc
PTCTNASDAQ
The average analyst price target for PTC Therapeutics is $86.23, 32.6% above the current price. Of 16 analysts, 13 rate it Buy, 2 Hold and 1 Sell. Targets range from $45 to $137. The latest change came on Nov 2, 2026, when Citigroup raised its price target on PTC Therapeutics from $108 to $109 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
